Insider trades
Emma Reeve, Director of Whitehawk Therapeutics WHWK, has filed 0 purchases and 27 sales on the open market. Over the past 12 months that comes to a net sale of $4.2M. The latest trade was on 06/12.
Emma Reeve
Director
- Company
- Whitehawk Therapeutics WHWK
- First filing
- 23/01/09
- Trades
- 73 trades
- Buys / sales
- 0 / 27
- 12-month net buying
- −$4.2M
- Last trade
- 06/12
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 01/05 | 01/06 | 734 sh | $76.00 | $55,784 | −6.4% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 25/12/03 | 25/12/05 | 733 sh | $78.62 | $57,628.46 | −9.9% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 25/11/21 | 25/11/25 | 10,000 sh | $79.50 | $795,000 | −60.0% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 25/11/12 | 25/11/14 | 7,333 sh | $74.50 | $546,308.5 | −52.4% |
PTCT | Open-market sale10b5-1 plan | 25/10/30 | 25/10/31 | 15,666 sh2 trades | $69.50avg. | $1,088,787 | −70.2% |
PTCT | Open-market sale10b5-1 plan | 25/10/03 | 25/10/07 | 25,562 sh9 trades | $65.96avg. | $1,686,023.74 | −71.2% |
PTCT | Open-market sale10b5-1 plan | 25/09/11 | 25/09/16 | 15,705 sh4 trades | $59.50avg. | $934,447.5 | −60.3% |
PTCT | Open-market sale10b5-1 plan | 23/05/22–23/05/23 | 23/05/24 | 9,768 sh6 trades | $59.53avg. | $581,499.76 | −57.6% |
PTCT | Open-market sale10b5-1 plan | 23/04/21 | 23/04/25 | 4,328 sh2 trades | $55.05avg. | $238,266.12 | −37.5% |
